← Back to Search

Behavioral Intervention

Telehealth Parent Training for PRT for Autism

N/A
Recruiting
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with ASD (based on history, review of available medical records including diagnostic testing, e.g., ADOS) or suspicion of ASD diagnosis and confirmed with Autism Diagnostic Interview-Revised (ADI-R; completed by phone)
An English-speaking parent able to consistently participate in study procedures
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 12
Awards & highlights

Study Summary

This trial will examine if training parents in Pivotal Response Treatment (PRT) for autism via secure video conferencing is effective, if parents can learn to deliver PRT in the home setting, and if their children will show greater improvement in functional communication skills.

Who is the study for?
This trial is for children aged 2 to 5 with Autism Spectrum Disorder (ASD) and significant language delays. They must have been diagnosed or suspected of ASD, speak English as a primary language, and have stable treatments with no major changes expected during the study. Children who receive extensive ABA therapy, live close to Stanford University, or have severe behavioral issues are not eligible.Check my eligibility
What is being tested?
The trial tests if parents can learn Pivotal Response Treatment (PRT) through video calls to help their kids improve communication skills. It compares kids getting PRT via telehealth against those on a waitlist. The study involves weekly sessions over three months and measures how well parents apply PRT and any progress in the child's verbal abilities.See study design
What are the potential side effects?
Since this intervention involves educational training without medical procedures or drugs, there aren't typical side effects like you'd see with medication. However, participating families may experience increased stress due to time commitment or frustration if improvements are not immediately observed.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with ASD or suspected to have it, confirmed by ADI-R.
Select...
I am an English-speaking parent who can participate in all study procedures.
Select...
I've been on a stable treatment plan for over 2 weeks with limited speech therapy.
Select...
I can speak clearly enough to be understood in a video.
Select...
My child is between 2 and 5 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Parent Fidelity of PRT Implementation from Baseline to Week 12
Secondary outcome measures
Change in Child Frequency of Functional Utterances from Baseline to Week 12

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PRT TelehealthExperimental Treatment1 Intervention
Participating parents will receive 12 weekly 60-minute parent training sessions via secure videoconference to learn Pivotal Response Treatment
Group II: WaitlistActive Control1 Intervention
Participants will continue stable community-based treatments
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pivotal Response Treatment
2016
N/A
~100

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,386 Previous Clinical Trials
17,333,968 Total Patients Enrolled
33 Trials studying Autism Spectrum Disorder
4,057 Patients Enrolled for Autism Spectrum Disorder

Media Library

Pivotal Response Treatment (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04042337 — N/A
Autism Spectrum Disorder Research Study Groups: Waitlist, PRT Telehealth
Autism Spectrum Disorder Clinical Trial 2023: Pivotal Response Treatment Highlights & Side Effects. Trial Name: NCT04042337 — N/A
Pivotal Response Treatment (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04042337 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current participant count for this medical study?

"Affirmative. Reported on clinicaltrials.gov, the study is actively trying to find participants and was initially posted on April 13th 2020 with its last update occurring October 13th 2022. 40 people across 1 medical centre need to be recruited for this research trial."

Answered by AI

Who qualifies for inclusion in this clinical experiment?

"This clinical trial is seeking 40 participants that are on the autism spectrum, aged between 2 and 5."

Answered by AI

Are there any available openings in this clinical trial for participants?

"Affirmative. The details posted on clinicaltrials.gov indicate that this research is actively enrolling participants, with the original posting being April 13th 2020 and a recent edit occuring October 13th 2022. In total, 40 patients are needed from 1 site to complete this study."

Answered by AI

Does this clinical study accept participants in the under-25 age group?

"This particular medical trail is searching for volunteers aged between 2 and 5 years old."

Answered by AI

Who else is applying?

What state do they live in?
New York
Florida
Pennsylvania
How old are they?
18 - 65
< 18
What portion of applicants met pre-screening criteria?
Did not meet criteria
~3 spots leftby Aug 2024